Ehrlichia chaffeensis and E. sennetsu, but Not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2258-2265

  Barnewall, Roy E ^a   Ohashi, Norio ^a   Rikihisa, Yasuko ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON REGULATORY FACTOR; IRON RESPONSIVE PROTEIN 1; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; CELL INCLUSION; CONTROLLED STUDY; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; GRANULOCYTE; HUMAN; HUMAN CELL; IRON RESPONSIVE ELEMENT; LEUKEMIA CELL; MESSENGER RNA SYNTHESIS; NEORICKETTSIA SENNETSU; NONHUMAN; PRIORITY JOURNAL;

EID: 0032900986     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2258-2265.1999     Document Type: Article

References (47)

1. Anderson, B. E., J. E. Dawson, D. C. Jones, and K. E. Wilson. 1991. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol. 29:2838-2842.
2. Bakken, J. S., J. S. Dumler, S. M. Chen, M. R. Eckman, L. L. van Etta, and D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper Midwest United States, a new species emerging? JAMA 272:212-218.
3. Bakken, J. S., J. Krueth, C. Wilson-Nordskogg, R. L. Tilden, K. Asanovich, and J. S. Dumler. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275:199-205.
4. Bakken, J. S., J. Krueth, R. L. Tilden, J. S. Dumler, and R. E. Kristansen. 1997. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur. J. Clin. Microbiol. Infect. Dis. 15:829-832.
5. Barnewall, R. E., and Y. Rikihisa. 1994. Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron transferrin. Infect. Immun. 62:4804-4810.
6. Barnewall, R. E., Y. Rikihisa, and E. H. Lee. 1997. Ehrlichia chaffeensis inclusions are early endosomes which selectively accumulate transferrin receptor. Infect. Immun. 65:1455-1461.
7. Brouqui, P., J. S. Dumler, R. Uenhard, M. Brassard, and D. Raoult. 1995. Human granulocytic ehrlichiosis in Europe. Lancet 346:782-783.
8. Byrd, T. F., and M. A. Horowitz. 1989. Interferon gamma-activated human monocytes down regulate transferrin receptors and inhibit the intracellular multiplication of Legionela pneumophila by limiting the availability of iron. J. Clin. Investig. 83:1457-1465.
9. Chen, S. M., J. S. Dumler, J. S. Bakken, and D. H. Walker. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595.
10. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347-350.
11. Dawson, J. E., B. E. Anderson, D. Fishbein, J. Sanchez, C. Goldsmith, K. Wilson, and C. Duntly. 1991. Isolation and characterization of an Ehrlichia sp. from a patient with human ehrlichiosis. J. Clin. Microbiol. 29:2741-2745.
12. Drapier, J. C., H. Hirling, J. Wietzerbin, P. Aldy, and L. Kuhn. 1993. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12:3643-3649.
13. Dumler, J. S. 1996. Human ehrlichioses: clinical, laboratory, epidemiologic, and pathologic considerations, p. 287-302. In J. Kazar and R. Toman (ed.), Proceedings of the Vth International Symposium on Rickettsiae and Rickettsial Diseases. Slovak Academy of Sciences, Bratislava, Slovak Republic.
14. Dumler, J. S., L. Dotevall, R. Gustafson, and M. Granstrom. 1997. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J. Infect. Dis. 175:720-722.
15. 14a. Eisenstein, R. S., P. T. Tuazon, K. L. Schalinske, S. A. Anderson, and J. A. Traugh. 1993. Iron-responsive element-binding protein: phosphorylation by protein kinase C. J. Biol. Chem. 268:27363-27370.
16. Fukuda, T., T. Kitao, and Y. Keida. 1954. Studies on the causative agent of "Hyuganestsu" disease. I. Isolation of the agent and its inoculation trial in human beings. Med. Biol. 23:200-209.
17. Gray, N. K., S. Quick, B. Goossen, A. Constable, H. Hirling, L. C. Kuhn, and M. W. Hentze. 1993. Recombinant iron-regulatory factor functions as an iron-responsive-element binding protein, a translational repressor and an aconitase: a functional assay for translational repression and direct demonstration of the iron switch. Eur. J. Biochem. 218:657-667.
18. Guerrero, A., D. B. Fishbein, E. Mesa, and R. Escudero. 1991. Human infection by Ehrlichia canis in Spain? Med. Clin. (Barcelona) 96:236-237.
19. Henderson, B. R., C. Seiser, and L. C. Kuhn. 1993. Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements. J. Biol. Chem. 268:27327-27334.
20. Hentze, W. M., T. A. Rouault, J. B. Harford, and R. D. Klausner. 1989. Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 244:357-359.
21. Jacobs, A. 1977. Low molecular weight intracellular iron transport compounds. Blood 50:433-439.
22. Maeda, K., N. Markowitz, R. C. Hawley, M. Ristic, D. Cox, and J. E. McDate. 1987. Human infection with Ehrlichia canis, a leukocytic rickettsia. N. Engl. J. Med. 316:853-856.
23. Martinez, J. L., A. Delgado Iribarren, and F. Baquero. 1990. Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol. Rev. 6:45-56.
24. Messick, J. B., and Y. Rikihisa. 1993. Characterization of Ehrlichia risticii binding, internalization, and proliferation in host cells by flow cytometry. Infect. Immun. 61:3803-3810.
25. Morais, J. D., J. E. Dawson, C. Greene, A. R. Filipe, L. C. Galhardas, and F. Bacellar. 1991. First European cases of ehrlichiosis. Lancet 338:633-634.
26. Mott, J., R. E. Barnewall, and Y. Rikihisa. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67:1368-1378.
27. a.Nunez, M.-T., V. Gaete, J. A. Watkins, and J. Glass. 1990. Mobilization of iron from endocytic vesicles. J. Biol. Chem. 265:6688-6692.
28. Paddock, C. D., J. W. Sumner, G. M. Merrill Shore, D. C. Bartley, R. C. Elie, J. G. McQuade, C. R. Martin, C. S. Goldsmith, and J. E. Childs. 1997. Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J. Clin. Microbiol. 35:2496-2502.
29. Park, J., and Y. Rikihisa. 1992. L-Arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon. Infect. Immun. 60:3504-3508.
30. Pierard, D., E. Levtchenko, J. E. Dawson, and S. Lauwers. 1995. Ehrlichiosis in Belgium. Lancet 346:1233-1234.
31. Rikihisa, Y. 1991. The tribe Ehrlichieae and ehrlichial diseases. Clin. Microbiol. Rev. 4:286-308.
32. Rikihisa, Y. 1996. Ehrlichiae, p. 272-286. In J. Kazar and R. Toman (ed.), Proceedings of the Vth International Symposium on Rickettsiae and Rickettsial Diseases. Slovak Academy of Sciences, Blatislava, Slovak Republic.
33. Rikihisa, Y. 1997. Ehrlichiae, emerging human pathogens, p. 332-345. In Y. Yanagihara and T. Masuzawa (ed.), Proceedings of the 2nd International Symposium on Lyme Disease in Shizuoka. Emerging and Re-Emerging Diseases Transmitted by Arthropod Vectors and Rodents. University of Shizuoka, Shizuoka, Japan.
34. Rikihisa, Y., N. Zhi, G. P. Wormser, B. Wen, H. M. Horowitz, and K. E. Hechemy. 1996. Ultrastructural and antigenic characterization of granulocytic ehrlichia directly isolated and cultivated from a patient in New York State. J. Infect. Dis. 175:210-213.
35. Rothenberger, S., B. J. Lacopetta, and L. C. Kuhn. 1987. Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell 49:423-431.
36. Samaniego, F., J. Chin, K. Iwai, T. A. Rouault, and R. D. Klausner. 1994. Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. J. Biol. Chem. 269:30904-39910.
37. Sumpton, K. J., J. M. Wright, S. J. Cutler, and B. S. S. Dale. 1995. Human ehrlichiosis in the UK. Lancet 346:1487-1488.
38. Telford, S. R., III, J. E. Dawson, C. K. Warner, C. P. Kolbert, and D. H. Persing. 1996. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl. Acad. Sci. USA 93:6209-6214.
39. Tsuchiya, S., M. Yamake, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of human monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
40. Uhaa, I. J., J. D. MacLean, C. R. Green, and D. B. Fishbein. 1992. A case of human ehrlichiosis acquired in Mali: clinical and laboratory findings. Am. J. Trop. Med. Hyg. 46:161-146.
41. Walker, D. H., and J. S. Dumler. 1996. Emergence of the ehrlichioses as human health problems. Emerg. Infect. Dis. 2:18-29.
42. 39a. Webster, P. J. W. Ijdo, L. M. Chicoine, and E. Fikrig. 1998. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment. J. Clin. Investig. 101:1932-1941.
43. Weiss, E., G. A. Dasch, Y.-H. Kang, and H. N. Westfall. 1988. Substrate utilization by Ehrlichia sennetsu and Ehrlichia risticii separated from host constituents by Renografin gradient centrifugation. J. Bacteriol. 170:5012-5017.
44. Wells, M. Y., and Y. Rikihisa. 1988. Lack of lysosomal fusion with phagosome containing Ehrlichia risticii in P388D, cells: abrogation of inhibition with oxytetracycline. Infect. Immun. 56:3209-3215.
45. Wormser, G., D. Mckenna, M. Aguero-Rosenfeld, et al. 1995. Human granulocytic ehrlichiosis-New York. Morbid. Mortal. Weekly Rep. 44:593-595.
46. Zhang, Y., N. Ohashi, E. H. Lee, A. Tamura, and Y. Rikihisa. 1997. Ehrlichia sennetsu groE operon and antigenic properties of the GroEL homolog. FEMS Immunol. Med. Microbiol. 18:39-46.
47. Zhang, Y., and Y. Rikihisa. Unpublished data.